About this trial
To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with common warts diagnosed clinically and by dermoscopy.
Patients older than 18years old.
Disqualifiers
Pregnancy and lactation.
Immunosuppression or being under any kind of treatment causing
absolute or relative immunosuppression.
Patients with chronic systemic diseases.
Trial population
\- study population age older than 18years
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Complete clearance rate of common warts.
Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: